Daytime sleepiness is one of the sleep disorders described in multiple sclerosis (MS) that can affect the quality of life of patients, especially in the presence of associated fatigue.
Daytime sleepiness is one of the sleep disorders described in multiple sclerosis (MS) that can affect the quality of life of patients, especially in the presence of associated fatigue.
Study the prevalence of daytime sleepiness in our multiple sclerosis patients.
Cross-sectional study carried out in the neurology department at CHU HASSAN II involving 50 patients. The scores used in this work are: the Epworth Sleepiness Scale, the Pittsburgh Sleep Quality Index (PSQI) score, the EMIF-SEP scale, and the EDSS.
The average age is 39.5 years with a predominance of women. The relapsing remitting form represents 84%, The average EDSS of the patients is 3.45. 60% have sleep disorders with a PSQI greater than 5, of which 34% of patients have daytime sleepiness.
Sleep disturbances are common and polymorphic in MS patients. Daytime sleepiness is a handicap during daily activity and can lead to serious accidents. It is often associated with fatigue and the distinction between the 2 symptoms is not obvious. Modafinil could improve both daytime sleepiness and fatigue.
Identifying and managing this sleep disorder could improve the quality of patients lives.